Review
Published on 17 Nov 2022
Immune checkpoint inhibitors for unresectable or metastatic pleomorphic dermal sarcomas
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.975342
- 4,429 views
- 12 citations
- Frontiers in Oncology
- Skin Cancer
- Articles
Type at least 3 characters
259 articles
Case Report
Published on 17 Nov 2022
Case report: Real-world experience using a personalized cancer-specific circulating tumor DNA assay in different metastatic melanoma scenarios
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.978996
- 2,762 views
- 4 citations
Original Research
Published on 14 Nov 2022
PCDH9 suppresses melanoma proliferation and cell migration
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.903554
- 3,411 views
- 4 citations
Original Research
Published on 07 Nov 2022
Development and validation of prognostic index based on immunogenic cell death-related genes with melanoma
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1011046
- 2,242 views
- 4 citations
Original Research
Published on 07 Nov 2022
Efficacy and toxicity of Ipilimumab-Nivolumab combination therapy in elderly metastatic melanoma patients
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1020058
- 9,353 views
- 11 citations
Original Research
Published on 02 Nov 2022
A population-based cohort study for presence of ulceration among cutaneous malignant melanoma subgroups of patients
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.929600
- 1,627 views
- 1 citation
Original Research
Published on 27 Oct 2022
Nomograms for predicting the prognosis of patients with penoscrotal extramammary Paget’s disease: A retrospective study in the SEER database and two medical centers
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.973579
- 1,948 views
- 2 citations
Original Research
Published on 20 Oct 2022
Methylation-driven gene DLL3 is a potential prognostic biomarker in ocular melanoma correlating with metastasis
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.964902
- 2,859 views
- 4 citations
Original Research
Published on 17 Oct 2022
Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1001150
- 8,160 views
- 40 citations
Mini Review
Published on 14 Oct 2022
Melanoma lymph node metastases – moving beyond quantity in clinical trial design and contemporary practice
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1021057
- 6,419 views
- 6 citations
Original Research
Published on 13 Oct 2022
Cutaneous verrucous carcinoma: A clinicopathological study of 21 cases with long-term clinical follow-up
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.953932
- 5,095 views
- 9 citations
Original Research
Published on 12 Oct 2022
A novel melanoma prognostic model based on the ferroptosis-related long non-coding RNA
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.929960
- 3,363 views
- 6 citations
Review
Published on 06 Oct 2022
Causes, consequences and clinical significance of aneuploidy across melanoma subtypes
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.988691
- 3,689 views
- 4 citations
Systematic Review
Published on 30 Sep 2022
The impact of merkel cell polyomavirus positivity on prognosis of merkel cell carcinoma: A systematic review and meta-analysis
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1020805
- 3,195 views
- 18 citations
Original Research
Published on 29 Sep 2022
Intermittent MEK inhibition for the treatment of metastatic uveal melanoma
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.975643
- 4,355 views
- 7 citations
Brief Research Report
Published on 23 Sep 2022
Treatment related toxicities with combination BRAF and MEK inhibitor therapy in resected stage III melanoma
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.855794
- 2,999 views
- 6 citations